Healthtech Startups

Carda Health provides at-home virtual cardiac and pulmonary rehabilitation for patients with conditions like COPD and heart disease, delivering physician-supervised care through clinical exercise physiologists with live vital-sign monitoring. The company ships patients a care kit and matches them with clinicians for personalized, remotely-supervised exercise, nutrition, and stress-management programs.

6 investors

Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.

6 investors

CareBridge provides 24/7 virtual and in-home healthcare services for individuals in home and community settings, serving health plans and their members. The company delivers clinical and behavioral health support through an interdisciplinary care team, complemented by in-home technology and electronic visit verification systems.

6 investors

CareCar connects health plan members with a network of caregivers to improve access to care services. The platform works with payers and health plans to facilitate connections between members and care partners.

6 investors

CareGuide operates online marketplaces that connect people seeking care services with qualified caregivers across various verticals including pet care, home services, and childcare. The platform aims to provide a simple and safe way for both caregivers and those needing care to connect.

6 investors

Carrum Health operates a value-based Centers of Excellence network that changes how specialty care is paid for and delivered, using bundled pricing to lower costs and improve outcomes. It serves employers and their patients through a specialty care platform in the healthcare payments space.

6 investors

Castlight Health provides digital health navigation solutions that help employees understand and use their benefits while enabling employers to manage benefit programs effectively through integrated, personalized services.

6 investors

CatalYm develops immunotherapies for solid tumors by neutralizing GDF-15, a factor cancer cells use to suppress immune responses and resist treatment. Its lead antibody, visugromab, is being advanced through clinical trials in combination with anti-PD-1 therapies to overcome cancer therapy resistance.

6 investors

CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods. The company serves pharmaceutical and specialty chemical manufacturers.

6 investors

Celerion is a contract research organization specializing in early phase clinical drug development, providing bioanalytical services and laboratory testing that generate clinical data for pharmaceutical clients. It focuses on early stage drug development to help clients make go/no-go decisions and bring drugs to market.

6 investors

CellCentric develops inobrodib, a small-molecule oral p300/CBP inhibitor intended to treat multiple myeloma and other cancers. The company focuses on cell fate control mechanisms to identify novel targets for cancer treatments and works with scientific and clinical centers of excellence.

6 investors

Cellibre engineers biological manufacturing by programming cells to produce industrial products through fermentation rather than traditional chemical synthesis. The company serves manufacturers seeking sustainable, cost-effective production of chemicals, materials, and other goods using cellular factories.

6 investors

Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.

6 investors

CG Oncology develops an investigational oncolytic immunotherapy for urologic cancer patients, specifically targeting BCG-unresponsive non-muscle invasive bladder cancer. The company's approach combines engineered viral immunotherapy with potential combination therapies to improve patient quality of life.

6 investors

Pharmaceutical company developing medicines and vaccines for patient health and treatment. Operating for over 130 years with focus on clinical research and drug development.

6 investors

Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones. The company is advancing clinical programs in immune-mediated inflammatory diseases, with a current focus on rheumatoid arthritis and hidradenitis suppurativa.

6 investors

Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches. It connects members with bilingual physicians, hospitals, and acupuncturists to deliver personalized care aligned with each community's cultural traditions and values.

6 investors

Coding Bio develops modular immunotherapies for cancer patients, using a high-throughput lab to screen millions of protein candidates in living cells and a machine learning platform to design and optimize therapies for immune activation. The company operates in the immuno-oncology and cell therapy space, aiming to accelerate development of CAR and related therapies.

6 investors

CoMind develops neuromonitoring devices and neural interfaces aimed at measuring and treating the brain to improve patient outcomes across the care continuum. It operates in the medical device and neurotechnology space serving clinical and healthcare settings.

6 investors

Commons Clinic is an orthopedic care provider offering treatment for spine, joint, and sports medicine conditions, along with preventive health services such as full-body MRI and biomarker labs. It serves patients in Los Angeles through a network of board-certified physicians and accepts major insurance plans.

6 investors

Conceivable builds AURA, a robotic automation platform that automates manual IVF laboratory procedures using physical AI, aiming to increase accessibility and affordability of in-vitro fertilization treatments.

6 investors

CopilotIQ provides AI-driven remote care management for older Americans with chronic conditions like diabetes and hypertension, combining high-frequency nurse care, connected devices, and a software platform (remoteIQ). The company merged with Biofourmis to create an end-to-end in-home care platform.

6 investors

Coral Care is a marketplace and technology company connecting families with licensed pediatric specialists — including speech, occupational, and physical therapists — who provide in-home care, accept insurance, and are available on demand. It serves families seeking early-intervention developmental care for children while giving clinicians autonomy, fair pay, and reduced administrative burden.

6 investors

CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions. The collapsible device is delivered via minimally invasive procedures and compresses the heart externally to increase cardiac output without the risks of blood clotting, stroke, or anticoagulation-related complications.

6 investors